Compounded, not FDA-approved
Sermorelin works upstream: it asks your pituitary for growth hormone instead of replacing it.
It was FDA-approved as Geref, later discontinued for commercial reasons, and FDA wrote into the federal record that the withdrawal was not about safety or effectiveness. We document what the human trials measured, what faded, and what was never shown, with every claim linked to its primary source.
- 37Cited primary sources
- 15Evidence-table entries, species-labeled
- 102In-depth guides
Online care, from intake to delivery
Sermorelin care, made simple
Choose your plan, complete a private medical intake, and connect with a licensed provider. If prescribed, treatment ships discreetly to your door.

Your care plan includes
Everything you need to get started
Encrypted checkout • provider review required • shipping included
- 01Choose your planSelect the supply and refill preference that works for you.
- 02Complete your intakeShare your health history in our private, secure flow.
- 03Provider reviewIf appropriate, your prescription is prepared and shipped.
Prescription treatment requires an online medical evaluation. A provider will determine whether treatment is medically appropriate; approval is not guaranteed.
Key facts
- StatusCompounded, not FDA-approved
- Parent half life6.8 minutes (GHRH 1-44 by HPLC) min
- Clearance39.7 mL/kg per min (GHRH 1-29)
- OnsetGH release within 10 minutes of SC injection
- Durationsingle GH pulse lasting about 2 hours
- Degradationcleaved by DPP-IV at the 2-3 bond to an inactive metabolite
- ClassGHRH analog (GRF 1-29)
- Half-lifeabout 4 minutes min
- RouteSubcutaneous injection; bedtime in trials
- Molecule29-amino-acid fragment of human GHRH
- First approvedDec 28, 1990 (Geref, diagnostic use)
- Discontinued2008, for commercial reasons
- GH response onsetwithin 10 min, lasting about 2 h
Browse by topic
Everything on sermorelin, organized the way you research it.
Free Sermorelin tools
Practical calculators and references, each scoped and sourced.
study rows by species, from the evidence table


All guides
102 in-depth, individually cited guides.
Comparisons 43 guides
Sourcing 19 guides
Evidence 17 guides
Dosing 14 guides
Safety 9 guides


Follow the sermorelin evidence as it changes
One short email when something real happens: a new trial, a safety signal, or an FDA move on sermorelin or its class, each item cited to its primary source.
